Canada Launches Multi-partner Glioblastoma Study | GenomeWeb

NEW YORK (GenomeWeb News) – A group of Canadian research institutes, universities, and funding partners have launched a C$8.2 million (US$8 million) effort to conduct molecular and genomic studies of glioblastoma tumors and develop targeted, personalized treatments for the deadly brain cancer, the Terry Fox Research Institute said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Sponsored by
Personal Genome Diagnostics

This webinar will highlight the key considerations and applications of next-generation sequencing for managing non-small cell lung cancer patients using plasma-based approaches. 

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.